Published in J Infect Dis on August 22, 2001
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88
Advances in Kawasaki disease. Eur J Pediatr (2004) 1.66
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Kawasaki disease. Yonsei Med J (2006) 1.16
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity (2010) 1.12
Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther (2010) 1.08
Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med (2011) 1.08
Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J Immunol (2009) 1.07
Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system". Yonsei Med J (2012) 1.01
Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2012) 0.98
Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr (2017) 0.92
The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol (2012) 0.92
Recent advances in the understanding and management of kawasaki disease. Curr Infect Dis Rep (2010) 0.89
Cardiovascular complications associated with chronic active Epstein-Barr virus infection. Pediatr Cardiol (2009) 0.88
Recent Advances in Kawasaki Disease. Yonsei Med J (2016) 0.88
Kawasaki disease: basic and pathological findings. Clin Exp Nephrol (2012) 0.86
BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children. Eur J Pediatr (2009) 0.85
Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy. Paediatr Child Health (2011) 0.85
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis. Comput Math Methods Med (2013) 0.84
Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy. Pediatr Res (2012) 0.84
Comparative effectiveness of intravenous immunoglobulin for children with Kawasaki disease: a nationwide cohort study. PLoS One (2013) 0.83
Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease. Clin Exp Immunol (2007) 0.82
CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease. Clin Exp Immunol (2003) 0.82
IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β. Arterioscler Thromb Vasc Biol (2015) 0.82
Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease. Korean J Pediatr (2012) 0.81
Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease. PLoS One (2014) 0.81
The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genomics (2015) 0.80
Alteration of CD4CD25Foxp3 T cell level in Kawasaki disease. Korean J Pediatr (2011) 0.80
CD84 is markedly up-regulated in Kawasaki disease arteriopathy. Clin Exp Immunol (2014) 0.78
Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. J Clin Immunol (2008) 0.78
Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. PLoS One (2016) 0.77
The CCR5 (-2135C/T) polymorphism may be associated with the development of Kawasaki disease in Korean children. J Clin Immunol (2008) 0.77
Found in Translation: International initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease. Arthritis Rheumatol (2016) 0.77
The roles of Ca2+/NFAT signaling genes in Kawasaki disease: single- and multiple-risk genetic variants. Sci Rep (2014) 0.76
GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease. J Exp Med (2016) 0.76
Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady. Open Forum Infect Dis (2016) 0.76
Infliximab treatment of pancreatitis complicating acute kawasaki disease. Pediatr Infect Dis J (2012) 0.76
Ambient Air Pollutant Exposures and Hospitalization for Kawasaki Disease in Taiwan: A Case-Crossover Study (2000-2010). Environ Health Perspect (2016) 0.75
Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. BMC Pharmacol Toxicol (2017) 0.75
CD8(+) T cells contribute to the development of coronary arteritis in the Lactobacillus casei extract-induced murine model of Kawasaki Disease. Arthritis Rheumatol (2016) 0.75
Kawasaki disease: a case report every otolaryngologist should know. Indian J Otolaryngol Head Neck Surg (2011) 0.75
Spontaneous closure of patent ductus arteriosus after an episode of Kawasaki disease: a case report. J Med Case Rep (2012) 0.75
IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease. Front Pharmacol (2017) 0.75
Arterial Immune Protein Expression Demonstrates the Complexity of Immune Responses in Kawasaki Disease Arteritis. Clin Exp Immunol (2017) 0.75
Urotensin 2 in Kawasaki disease pathogenesis. Pediatr Res (2017) 0.75
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens. Am J Clin Pathol (1970) 8.90
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (1999) 5.53
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med (2000) 5.05
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell (1998) 3.42
Agrobacterium rhizogenes-transformed roots of Medicago truncatula for the study of nitrogen-fixing and endomycorrhizal symbiotic associations. Mol Plant Microbe Interact (2001) 3.25
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat Genet (2000) 2.53
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1980) 2.47
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Expression of rotavirus VP2 produces empty corelike particles. J Virol (1991) 2.38
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J Virol (1987) 2.29
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med (1993) 2.16
Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis (1989) 2.09
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol (1996) 2.07
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol (1997) 1.96
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A (2001) 1.83
Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses. Clin Diagn Lab Immunol (1999) 1.77
Abandoning empirical antibiotics for febrile children. Lancet (1997) 1.75
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med (2000) 1.70
Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2000) 1.67
Kawasaki disease in infants less than one year of age. J Pediatr (1995) 1.67
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.65
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr (1997) 1.64
Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics (1999) 1.61
Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA (1997) 1.61
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr (1991) 1.60
IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis (2000) 1.58
Clinical aspects of acute rheumatic fever. J Rheumatol Suppl (1991) 1.57
Balloon-expandable intracoronary stents in the adult dog. Circulation (1987) 1.56
Kawasaki syndrome. Rev Infect Dis (1988) 1.55
Kawasaki syndrome. Pediatr Clin North Am (1999) 1.53
Randomized trial of partial vs. stepwise caries removal: 3-year follow-up. J Dent Res (2012) 1.51
Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg (2000) 1.50
Analysis of charges and complications of permanent pacemaker implantation in the cardiac catheterization laboratory versus the operating room. Pacing Clin Electrophysiol (1999) 1.49
Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr (1988) 1.49
Rotavirus NSP4 induces a novel vesicular compartment regulated by calcium and associated with viroplasms. J Virol (2006) 1.49
Evaluation of an ELISA for group A streptococcal antigen for diagnosis of pharyngitis. J Pediatr (1987) 1.47
Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod (2000) 1.47
Incomplete Kawasaki disease with coronary artery involvement. J Pediatr (1987) 1.46
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol (1997) 1.44
Incubation period necessary to detect bacteremia in neonates. Pediatr Infect Dis (1986) 1.41
Community acquired Pseudomonas aeruginosa urinary tract infection in preschool children. Pediatr Nephrol (1997) 1.41
Two glycoproteins are produced from the rotavirus neutralization gene. Virology (1986) 1.41
[Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model]. Encephale (2008) 1.39
Scleritis and Wegener's granulomatosis in children. Am J Ophthalmol (1991) 1.39
Rotavirus SA11 genome segment 11 protein is a nonstructural phosphoprotein. J Virol (1989) 1.37
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics (1983) 1.33
Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev (2001) 1.33
Rotavirus proteins: structure and assembly. Curr Top Microbiol Immunol (2006) 1.30
Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate (2001) 1.29
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology (1998) 1.29
Kawasaki syndrome. Clin Microbiol Rev (1998) 1.28
Candidemia in a pediatric population. Clin Infect Dis (1995) 1.28
Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology (1986) 1.27
Rotavirus vaccine administered parenterally induces protective immunity. J Virol (1993) 1.27
Does Kawasaki disease have a retroviral aetiology? Lancet (1986) 1.26
Bimodal atomic force microscopy imaging of isolated antibodies in air and liquids. Nanotechnology (2008) 1.25
Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir. J Clin Microbiol (1987) 1.25
Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol (1998) 1.23
Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics (1994) 1.23
Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr (1985) 1.21
Neurocysticercosis among children in Chicago. Clin Infect Dis (1996) 1.21
Cardiac plasma cell granulomas: response to oral steroid treatment. Pediatr Cardiol (2004) 1.21
Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp (2001) 1.20
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20
Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol (2001) 1.19
Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J (1987) 1.19
Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control (2001) 1.18
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis (1997) 1.16
Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. J Infect Dis (1981) 1.16
Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol (2001) 1.16
Kawasaki disease in older children and adolescents. J Pediatr (2000) 1.15
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection. Clin Infect Dis (2005) 1.13
Cardiac transplantation for Kawasaki disease. Pediatrics (1997) 1.13
Periorbital and orbital cellulitis in children. Pediatrics (1978) 1.13
Luminosity-independent measurement of the proton-proton total cross section at √s=8 TeV. Phys Rev Lett (2013) 1.13
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. J Infect Dis (1986) 1.12
Congenital, infiltrating giant-cell angioblastoma. A new entity? Am J Surg Pathol (1991) 1.11
Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child (1987) 1.09
Timely diagnosis of congenital infections. Pediatr Clin North Am (1994) 1.08
Herpes simplex type 2 in a patient with Mollaret's meningitis: demonstration by polymerase chain reaction. Ann Neurol (1994) 1.08
Adhesion to and invasion of cultured human cells by Bartonella bacilliformis. Infect Immun (1992) 1.08